About Omnyx
Omnyx is a Healthcare company based in Pittsburgh (United States) founded in 2008, and was acquired by Inspirata in January 2018. Digital pathology solutions are offered for oncology applications. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its competitors include PathAI, PAIGE and EnSpectra Health; 3 of its 3 listed competitors have raised funding.
Company details
Omnyx was founded in 2008 in Pittsburgh, United States, focusing on the oncology sector through digital pathology. Continuous flow glass-to-digital scanners are utilized, alongside software for expediting diagnoses and digitizing case files. Turnkey pathology consulting services are also provided. The initial application targets breast cancer in both clinical and research environments, supporting pathology workflows.
Investors in Omnyx
Omnyx has secured backing from 1 investor. Prominent investors backing the company include Inspirata.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Digital pathology solutions for cancer diagnostics are developed by Inspirata. | 2014 | inspirata.com | Tampa, United States |
Investor details for Omnyx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Omnyx
2 dated milestones of Omnyx across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Omnyx is founded.
- Exit Acquired by Inspirata.
Competitors of Omnyx
Omnyx has 3 listed competitors in our database, 3 of them funded. They include PathAI, PAIGE and EnSpectra Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pathai.com | 2016 | Boston, United States | $254.94M | 573 | Provider of AI-based solutions for clinical diagnosis of cancer and other diseases | |
| paige.ai | 2018 | New York, United States | $241M | AI-enabled tools for computational pathology and cancer diagnostics are provided. | ||
| enspectrahealth.com | 2014 | Mountain View, United States | $15.55M | 8 | Developer of medical devices for tissue imagining and cancer detection |
Detailed competitors of Omnyx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Omnyx (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Omnyx
Omnyx was founded in 2008.
Omnyx is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Omnyx was founded in 2008 in Pittsburgh, United States, focusing on the oncology sector through digital pathology. Continuous flow glass-to-digital scanners are utilized, alongside software for expediting diagnoses and digitizing case files. Turnkey pathology consulting services are also provided. The initial application targets breast cancer in both clinical and research environments, supporting pathology workflows.
Omnyx's top competitors include PathAI, PAIGE and EnSpectra Health.
Omnyx has 1 investor. Key investors include Inspirata.
Yes. Omnyx was acquired by Inspirata in January 2018.